HOMER2

Chr 15AD

homer scaffold protein 2

Also known as: ACPD, CPD, DFNA68, HOMER-2, VESL-2

This gene encodes a member of the homer family of dendritic proteins. Members of this family regulate group 1 metabotrophic glutamate receptor function. The encoded protein is a postsynaptic density scaffolding protein. Alternative splicing results in multiple transcript variants. Two related pseudogenes have been identified on chromosome 14. [provided by RefSeq, Jun 2011]

OMIMResearchGenerating clinical summary…
DNmechanismADLOEUF 0.661 OMIM phenotype
Clinical SummaryHOMER2
🧬
Gene-Disease Validity (ClinGen)
nonsyndromic genetic hearing loss · ADModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
5 unique Pathogenic / Likely Pathogenic· 93 VUS of 225 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.66LOEUF
pLI 0.009
Z-score 2.69
OE 0.35 (0.200.66)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.31Z-score
OE missense 0.94 (0.831.06)
195 obs / 207.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.35 (0.200.66)
00.351.4
Missense OE?0.94 (0.831.06)
00.61.4
Synonymous OE?0.93
01.21.6
LoF obs/exp: 7 / 20.0Missense obs/exp: 195 / 207.7Syn Z: 0.49

This gene — mechanism propensity

DN
0.79top 25%
GOF
0.5464th %ile
LOF
0.3549th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median · 1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNThese data provide compelling evidence that HOMER2 is required for normal hearing and that its sequence alteration in humans leads to ADNSHL through a dominant-negative mode of action.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 25816005

ClinVar Variant Classifications

225 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic2
VUS93
Likely Benign74
Benign32
Conflicting11
3
Pathogenic
2
Likely Pathogenic
93
VUS
74
Likely Benign
32
Benign
11
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
1
0
0
3
Likely Pathogenic
2
0
0
0
2
VUS
6
82
3
2
93
Likely Benign
1
14
34
25
74
Benign
0
2
26
4
32
Conflicting
11
Total11996331215

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

34 pathogenic / likely-pathogenic (of 39) ClinVar copy-number / structural variants overlap HOMER2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

HOMER2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →